- Home
- PHAT vs NFGC Comparison
PHAT vs NFGC Comparison
Compare PHAT & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- NFGC
- Stock Information
- Founded
- PHAT 2018
- NFGC 2016
- Country
- PHAT United States
- NFGC Canada
- Employees
- PHAT N/A
- NFGC N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- NFGC Precious Metals
- Sector
- PHAT Health Care
- NFGC Basic Materials
- Exchange
- PHAT Nasdaq
- NFGC Nasdaq
- Market Cap
- PHAT 289.0M
- NFGC 261.0M
- IPO Year
- PHAT 2019
- NFGC N/A
- Fundamental
- Price
- PHAT $8.92
- NFGC $1.49
- Analyst Decision
- PHAT Strong Buy
- NFGC Strong Buy
- Analyst Count
- PHAT 4
- NFGC 1
- Target Price
- PHAT $16.25
- NFGC $5.00
- AVG Volume (30 Days)
- PHAT 4.4M
- NFGC 2.2M
- Earning Date
- PHAT 05-01-2025
- NFGC 05-12-2025
- Dividend Yield
- PHAT N/A
- NFGC N/A
- EPS Growth
- PHAT N/A
- NFGC N/A
- EPS
- PHAT N/A
- NFGC N/A
- Revenue
- PHAT $81,859,000.00
- NFGC N/A
- Revenue This Year
- PHAT $195.45
- NFGC N/A
- Revenue Next Year
- PHAT $106.76
- NFGC N/A
- P/E Ratio
- PHAT N/A
- NFGC N/A
- Revenue Growth
- PHAT 3055.70
- NFGC N/A
- 52 Week Low
- PHAT $2.21
- NFGC $0.93
- 52 Week High
- PHAT $19.71
- NFGC $3.65
- Technical
- Relative Strength Index (RSI)
- PHAT 82.93
- NFGC 58.15
- Support Level
- PHAT $4.47
- NFGC $1.44
- Resistance Level
- PHAT $4.99
- NFGC $1.61
- Average True Range (ATR)
- PHAT 0.89
- NFGC 0.12
- MACD
- PHAT 0.39
- NFGC 0.02
- Stochastic Oscillator
- PHAT 60.60
- NFGC 54.13
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).